Search

Search Results
Results 421 - 430 of 967 for allergy
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Olamlo HCT (Olmesartan medoxomil, amlodipine and hydrochlorothiazide) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Noten intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Nevirapine Viatris intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Flosix intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooke (drospirenone 3 mg and ethinylestradiol 20 micrograms) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Drug - 24 Mar 2023
    Consumer Medicine Information (CMI) about Abisart intended for persons living in Australia.
  • Drug - 9 Feb 2023
    Consumer Medicine Information (CMI) about Rixadone Oral (Risperidone Oral solution 1mg/mL) intended for persons living in Australia.
  • Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about Duoplidogrel intended for persons living in Australia.
  • Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about DuoCover intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.